- Home
- EVCM vs IDYA Comparison
EVCM vs IDYA Comparison
Compare EVCM & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVCM
- IDYA
- Stock Information
- Founded
- EVCM 2006
- IDYA 2015
- Country
- EVCM United States
- IDYA United States
- Employees
- EVCM N/A
- IDYA N/A
- Industry
- EVCM EDP Services
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- EVCM Technology
- IDYA Health Care
- Exchange
- EVCM Nasdaq
- IDYA Nasdaq
- Market Cap
- EVCM 1.8B
- IDYA 2.0B
- IPO Year
- EVCM 2021
- IDYA 2019
- Fundamental
- Price
- EVCM $9.55
- IDYA $21.67
- Analyst Decision
- EVCM Buy
- IDYA Strong Buy
- Analyst Count
- EVCM 12
- IDYA 12
- Target Price
- EVCM $11.67
- IDYA $54.27
- AVG Volume (30 Days)
- EVCM 206.3K
- IDYA 1.2M
- Earning Date
- EVCM 08-05-2025
- IDYA 08-05-2025
- Dividend Yield
- EVCM N/A
- IDYA N/A
- EPS Growth
- EVCM N/A
- IDYA N/A
- EPS
- EVCM N/A
- IDYA N/A
- Revenue
- EVCM $703,186,000.00
- IDYA $7,000,000.00
- Revenue This Year
- EVCM N/A
- IDYA $101.20
- Revenue Next Year
- EVCM $6.31
- IDYA $286.70
- P/E Ratio
- EVCM N/A
- IDYA N/A
- Revenue Growth
- EVCM 7.84
- IDYA N/A
- 52 Week Low
- EVCM $8.10
- IDYA $13.45
- 52 Week High
- EVCM $12.35
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- EVCM 39.61
- IDYA 58.21
- Support Level
- EVCM $9.44
- IDYA $21.09
- Resistance Level
- EVCM $9.82
- IDYA $22.50
- Average True Range (ATR)
- EVCM 0.29
- IDYA 0.97
- MACD
- EVCM -0.06
- IDYA -0.04
- Stochastic Oscillator
- EVCM 14.01
- IDYA 56.44
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.